Crescendo Bioscience Garners $28,000,000 Series D Financing Round

  • Feed Type
  • Date
    1/3/2013
  • Company Name
    Crescendo Bioscience
  • Mailing Address
    341 Oyster Point Blvd South San Francisco, CA 94080
  • Company Description
    Crescendo Bioscience is developing a broad range of quantitative, objective diagnostic tools to provide Rheumatologists with deeper clinical insights to more effectively manage patients with autoimmune and inflammatory diseases.
  • Website
    http://www.crescendobio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $28,000,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    This round of funding will enable Crescendo to accelerate its commercialization efforts for Vectra DA, a novel test which assesses disease activity in rheumatoid arthritis patients.
  • M&A Terms
  • Venture Investor
    Skyline Ventures
  • Venture Investor
    Safeguard Scientifics
  • Venture Investor
    Mohr Davidow Ventures
  • Venture Investor
    Kleiner Perkins Caufield & Byers
  • Venture Investor
    Aeris Capital AG

By posting a comment, you agree to our terms and conditions.